Lefort, M. Et Al. 2022. Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis. BMC MEDICAL RESEARCH METHODOLOGY , vol.22, no.1 .

Lefort, M., Sharmin, S., Andersen, J. B., Vukusic, S., Casey, R., Debouverie, M., ... Edan, G.(2022). Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis. BMC MEDICAL RESEARCH METHODOLOGY , vol.22, no.1.

Lefort, M. Et Al. "Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis," BMC MEDICAL RESEARCH METHODOLOGY , vol.22, no.1, 2022

Lefort, M. Et Al. "Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis." BMC MEDICAL RESEARCH METHODOLOGY , vol.22, no.1, 2022

Lefort, M. Et Al. (2022) . "Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis." BMC MEDICAL RESEARCH METHODOLOGY , vol.22, no.1.

@article{article, author={M. Lefort Et Al. }, title={Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis}, journal={BMC MEDICAL RESEARCH METHODOLOGY}, year=2022}